Pea vs Whey Protein Supplementation With Resistance Training on Young Adults' Strength, Body Composition, and Metabolic Parameters

February 16, 2026 updated by: Texas Woman's University

The Effect of Pea Protein Supplementation on Muscle Hypertrophy and Metabolic Parameters in Young Adults Following an 8-week Resistance Training Program

The goal of this clinical trial is to compare the impact of pea protein or whey protein supplementation during a progressive resistance exercise (PRE) regimen on body composition and strength in young adults who are not undergoing regular strength training. The main questions it aims to answer are:

  1. Do lean body mass changes differ between supplement groups following a progressive resistance exercise PRE training program?
  2. Does improvements in muscle strength differ between groups following a PRE training program?
  3. Does glucose, insulin, and essential amino acid appearance and clearance rate differ between groups following a PRE training program? Researchers will compare pea protein supplementation to whey protein supplementation to see if there are any differences in body composition and strength

Participants will:

  • Consume Pea or Whey protein supplement twice daily for 8 weeks
  • Participate in a PRE training program twice weekly for approximately 1.5 hours per day

Study Overview

Detailed Description

Adequate dietary protein intake is essential for maximizing skeletal muscle hypertrophy and strength gains during progressive resistance exercise (PRE) training. Whey protein isolate is commonly used to support these adaptations; however, there is limited clinical evidence comparing plant-based protein supplements with whey protein when protein dose is controlled and combined with structured resistance training. Pea protein isolate represents a sustainable, plant-based alternative, but its effectiveness in promoting muscle accretion, strength, and metabolic responses relative to whey protein isolate has not been fully characterized. Therefore, this study will compare the effects of pea protein isolate and whey protein isolate supplementation on changes in lean body mass, muscle strength, and postprandial metabolic responses in healthy, untrained young adult males. Participants will be randomized in a double-blind, parallel-group design to consume either pea protein isolate or whey protein isolate for 8 weeks while completing a supervised, PRE training program. Lean body mass and strength outcomes will be assessed before and after the intervention, and acute postprandial essential amino acid, glucose, and insulin responses will be evaluated following standardized protein ingestion at baseline and post-intervention.

Study Type

Interventional

Enrollment (Actual)

34

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Texas
      • Houston, Texas, United States, 77008
        • Texas Woman's University Institute of Health Sciences Houston Center

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Healthy Adults 18-30y
  • BMI between 18.5 - 28 kg/m**2

The subjects will be excluded if:

  • they have a history or current diagnosis of cardiovascular disease, cancer, diabetes, gastrointestinal disorders, or metabolic disorders.
  • they use tobacco products
  • consume alcohol as defined as >2 drinks per day,
  • follow a special diet
  • reported recent significant body weight changes (>5% prior 3 months)
  • report an intolerance or allergy to ingredients in the supplements.
  • report regular consumption of other muscle or metabolic stimulating products or drugs such as creatine, other amino acids or protein supplements, growth hormone or derivatives, or ergogenic aids including steroids.
  • if they answer "no" to any question on the Physical Activity Readiness Questionnaire which would indicate that the subject cannot safely participate in an exercise program.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Basic Science
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Pea Protein
Participants in this arm will consume pea protein isolate (24g/sachet) twice daily for 8 weeks while participating in an 8-week PRE program (2, 1.5hr sessions per week)
Participants in this arm will consume protein isolate (24g/sachet) twice daily for 8 weeks.

Based on the resistance training guidelines from the American College of Sports Medicine, each subject will attend two supervised resistance training sessions weekly for a duration of 8 weeks. A minimum two day rest between PRE sessions will be required. Twelve exercises that targets each major muscle group will be conducted at each exercise session in the order listed below:

  1. Seated chest press
  2. Lat pulldown
  3. Military Press
  4. Seated row
  5. Bicep Curl
  6. Triceps Extension
  7. Leg Press
  8. Leg extension
  9. Leg Curl
  10. Heel Raise
  11. Abdominal curls
  12. Back extension At the first exercise session, each subject's 1-RM will be estimated for the exercises listed above
Active Comparator: Whey Protein
Participants in this arm will consume whey protein isolate (24g/sachet) twice daily for 8 weeks while participating in an 8-week PRE program (2, 1.5hr sessions per week)
Participants in this arm will consume protein isolate (24g/sachet) twice daily for 8 weeks.

Based on the resistance training guidelines from the American College of Sports Medicine, each subject will attend two supervised resistance training sessions weekly for a duration of 8 weeks. A minimum two day rest between PRE sessions will be required. Twelve exercises that targets each major muscle group will be conducted at each exercise session in the order listed below:

  1. Seated chest press
  2. Lat pulldown
  3. Military Press
  4. Seated row
  5. Bicep Curl
  6. Triceps Extension
  7. Leg Press
  8. Leg extension
  9. Leg Curl
  10. Heel Raise
  11. Abdominal curls
  12. Back extension At the first exercise session, each subject's 1-RM will be estimated for the exercises listed above

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Difference in body composition
Time Frame: Baseline and 8 weeks
Differences in lean mass (kg, kg/m^2, and % total mass) and fat mass (kg, and % total mass) assessed using Dual Energy X-ray Absorptiometry (DXA; Horizon W, Hologic, Marlborough, MA)
Baseline and 8 weeks
Difference in muscle strength
Time Frame: Baseline and 8 weeks
Differences in muscle strength assessed by maximal isometric force produced by quadriceps (Nm) using a Biodex System 3 dynamometer, hand grip (kg) using a handgrip dynamometer, 1-Rep Max for chest press (kg), and 1-Rep Max for leg press (kg)
Baseline and 8 weeks

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Nutritional Metabolic Biomarkers
Time Frame: Baseline and 8 weeks
Differences in essential amino acid (Histidine, isoleucine, leucine, lysine, methionine, phenylalanine, threonine, tryptophan, and valine) cMax and iAUC, glucose (cMax and iAUC), and insulin (cMax and iAUC) will be measured from plasma following a protein load (0.3 g/kg body weight of pea- or whey-protein isolate)
Baseline and 8 weeks

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Resting Metabolic Rate
Time Frame: Baseline and 8 weeks
Differences in Resting Metabolic Rate (kcal/d) will be measured using indirect calorimetry (Parvo Medics TrueOne 2400, Parvo Medics, Sandy, UT)
Baseline and 8 weeks
Blood Pressure
Time Frame: Baseline and 8 weeks
Systolic (mmHg) and diastolic (mmHg) blood pressure measured using digital blood pressure monitor (Spot Vital Signs 4200B, Welch Allyn, Skaneateles Falls, NY)
Baseline and 8 weeks
Weight status
Time Frame: Baseline and 8 weeks
Body Mass Index (kg/m**2) calculated from measured body weight (kg) and height (cm) using digital scale and stadiometer, respectively. Body weight (kg)
Baseline and 8 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 3, 2024

Primary Completion (Actual)

December 6, 2025

Study Completion (Actual)

December 6, 2025

Study Registration Dates

First Submitted

December 19, 2025

First Submitted That Met QC Criteria

February 16, 2026

First Posted (Actual)

February 19, 2026

Study Record Updates

Last Update Posted (Actual)

February 19, 2026

Last Update Submitted That Met QC Criteria

February 16, 2026

Last Verified

December 1, 2025

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Healthy Subjects

Clinical Trials on Protein Isolate

Subscribe